Selegiline Improves Cognitive Impairment in the Rat Model of Alzheimer's Disease.
Alzheimer’s disease
Long-term potentiation
Oxidative stress
Selegiline
Spatial memory
Journal
Molecular neurobiology
ISSN: 1559-1182
Titre abrégé: Mol Neurobiol
Pays: United States
ID NLM: 8900963
Informations de publication
Date de publication:
13 Aug 2024
13 Aug 2024
Historique:
received:
21
11
2023
accepted:
19
07
2024
medline:
13
8
2024
pubmed:
13
8
2024
entrez:
13
8
2024
Statut:
aheadofprint
Résumé
Alzheimer's disease (AD) is a progressive neurological disorder characterized by cognitive decline. This study was undertaken to evaluate the effects of selegiline (SEL) against AD-induced cognitive deficits and explore the possible involved mechanisms. AD was induced by unilateral intracerebroventricular (U-ICV) injection of 5 μg of amyloid beta
Identifiants
pubmed: 39136906
doi: 10.1007/s12035-024-04388-x
pii: 10.1007/s12035-024-04388-x
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM (2021) Alzheimer’s disease. Lancet 397(10284):1577–1590
pubmed: 33667416
pmcid: 8354300
doi: 10.1016/S0140-6736(20)32205-4
Armstrong RA (2019) Risk factors for Alzheimer’s disease. Folia Neuropathol 57(2):87–105
doi: 10.5114/fn.2019.85929
Breijyeh Z, Karaman R (2020) Comprehensive review on Alzheimer’s disease: causes and treatment. Molecules 25(24):5789
pubmed: 33302541
pmcid: 7764106
doi: 10.3390/molecules25245789
Armstrong RA (2009) The molecular biology of senile plaques and neurofibrillary tangles in Alzheimer’s disease. Folia Neuropathol 47(4):289–299
pubmed: 20054780
Tamagno E, Guglielmotto M, Vasciaveo V, Tabaton M (2021) Oxidative stress and beta amyloid in Alzheimer’s disease Which comes first: the chicken or the egg? Antioxidants 10(9):1479
pubmed: 34573112
pmcid: 8468973
doi: 10.3390/antiox10091479
Emilsson L, Saetre P, Balciuniene J, Castensson A, Cairns N, Jazin EE (2002) Increased monoamine oxidase messenger RNA expression levels in frontal cortex of Alzheimer’s disease patients. Neurosci Lett 326(1):56–60
pubmed: 12052537
doi: 10.1016/S0304-3940(02)00307-5
Gulyás B, Pavlova E, Kása P, Gulya K, Bakota L, Várszegi S, Keller E, Horváth MC et al (2011) Activated MAO-B in the brain of Alzheimer patients, demonstrated by [11C]-L-deprenyl using whole hemisphere autoradiography. Neurochem Int 58(1):60–68
Rahman K (2007) Studies on free radicals, antioxidants, and co-factors. Clin Interv Aging 2(2):219–236
pubmed: 18044138
pmcid: 2684512
Carter SF, Schöll M, Almkvist O, Wall A, Engler H, Långström B, Nordberg A (2012) Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. J Nucl Med 53(1):37–46
pubmed: 22213821
doi: 10.2967/jnumed.110.087031
Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G, Andronie-Cioara FL, Toma MM et al (2021) Role of monoamine oxidase activity in Alzheimer’s disease: an insight into the therapeutic potential of inhibitors. Molecules 26(12):3724
Waters CH, Sethi KD, Hauser RA, Molho E, Bertoni JM (2004) Zydis selegiline reduces off time in Parkinson’s disease patients with motor fluctuations: a 3-month, randomized, placebo-controlled study. Mov Disord 19(4):426–432
pubmed: 15077240
doi: 10.1002/mds.20036
Pu Y, Qian F, Guo J, Sha Y, Qian Y (2022) Selegiline protects against lipopolysaccharide (LPS)–induced impairment of the blood–brain barrier through regulating the NF-κB/MLCK/p-MLC signaling pathway. Neurotox Res 40(1):267–275
pubmed: 34981455
doi: 10.1007/s12640-021-00448-5
Magyar K, Szende B (2004) (−)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties. Neurotoxicology 25(1–2):233–242
pubmed: 14697898
doi: 10.1016/S0161-813X(03)00102-5
Wu Y, Kazumura K, Maruyama W, Osawa T, Naoi M (2015) Rasagiline and selegiline suppress calcium efflux from mitochondria by PK11195-induced opening of mitochondrial permeability transition pore: a novel anti-apoptotic function for neuroprotection. J Neural Transm 122:1399–1407
pubmed: 25863936
doi: 10.1007/s00702-015-1398-0
Abdanipour A, Mirzaei M, Anarkooli IJ, Mohammadi P (2023) Effect of selegiline as a monomine oxidase B inhibitor on the expression of neurotrophin mRNA levels in a contusion rat model of spinal cord injury. Neurol Res 45(3):241–247
pubmed: 36453689
doi: 10.1080/01616412.2022.2129761
Gyárfás T, Knuuttila J, Lindholm P, Rantamäki T, Castrén E (2010) Regulation of brain-derived neurotrophic factor (BDNF) and cerebral dopamine neurotrophic factor (CDNF) by anti-parkinsonian drug therapy in vivo. Cell Mol Neurobiol 30:361–368
pubmed: 19777340
doi: 10.1007/s10571-009-9458-3
Amini-Khoei H, Saghaei E, Mobini G-R, Sabzevary-Ghahfarokhi M, Ahmadi R, Bagheri N, Mokhtari T (2019) Possible involvement of PI3K/AKT/mTOR signaling pathway in the protective effect of selegiline (deprenyl) against memory impairment following ischemia reperfusion in rat. Neuropeptides 77:101942
pubmed: 31272684
doi: 10.1016/j.npep.2019.101942
Knoll J (1989) The pharmacology of selegiline ((−) deprenyl) New aspects. Acta Neurologica Scandinavica 80:83–91
doi: 10.1111/j.1600-0404.1989.tb01787.x
Soliman GF, Hashem G, Fawzy MG, Ibrahim W (2019) Neuroprotective effects of metformin versus selegiline on Parkinson’s disease model by reserpine through the interrelation of α synuclein and antioxidants on behavioral changes in rats. Egypt J Basic Clin Pharmacol 9
Maia F, Pitombeira B, Araujo D, Cunha G, Viana G (2004) l-Deprenyl prevents lipid peroxidation and memory deficits produced by cerebral ischemia in rats. Cell Mol Neurobiol 24:87–100
pubmed: 15049513
doi: 10.1023/B:CEMN.0000012727.59502.c5
Goverdhan P, Sravanthi A, Mamatha T (2012) Neuroprotective effects of meloxicam and selegiline in scopolamine-induced cognitive impairment and oxidative stress. Int J Alzheimer’s Disease 2012:974013
Wahdan SA, Tadros MG, Khalifa AE (2017) Antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats. Naunyn-Schmiedeberg’s Arch Pharmacol 390:905–917
doi: 10.1007/s00210-017-1392-1
Zhu J, Hamm R, Reeves T, Povlishock J, Phillips L (2000) Postinjury administration of L-deprenyl improves cognitive function and enhances neuroplasticity after traumatic brain injury. Exp Neurol 166(1):136–152
pubmed: 11031090
doi: 10.1006/exnr.2000.7484
Ahmari M, Sharafi A, Mahmoudi J, Jafari-Anarkoli I, Gharbavi M, Hosseini M-J (2020) Selegiline (l-deprenyl) mitigated oxidative stress, cognitive abnormalities, and histopathological change in rats: alternative therapy in transient global ischemia. J Mol Neurosci 70:1639–1648
pubmed: 32488846
doi: 10.1007/s12031-020-01544-5
Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M et al (2008) Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. Hum Psychopharmacol Clin Exp 23(2):79–86
Gerlach M, Youdim M, Riederer P (1996) Pharmacology of selegiline. Neurology 47 (6_suppl_3) 137S-145S
LI G (1964) Monoamine oxidase inhibitors Adverse reactions and possible mechanisms. JAMA 190:456–462
Ishikawa T, Okano M, Minami A, Tsunekawa H, Satoyoshi H, Tsukamoto Y, Takahata K et al (2019) Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity. Behav Brain Res 359:353–361
Pazini AM, Gomes GM, Villarinho JG, Da Cunha C, Pinheiro F, Ferreira AP, Mello CF, Ferreira J et al (2013) Selegiline reverses Aβ 25–35-induced cognitive deficit in male mice. Neurochem Res 38:2287–2294
Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J et al (1997) A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer’s disease. N Engl J Med 336(17):1216–1222
Thomas T (2000) Monoamine oxidase-B inhibitors in the treatment of Alzheimers disease. Neurobiol Aging 21(2):343–348
pubmed: 10867219
doi: 10.1016/S0197-4580(00)00100-7
Tsunekawa H, Noda Y, Mouri A, Yoneda F, Nabeshima T (2008) Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25–35). Behav Brain Res 190(2):224–232
pubmed: 18420288
doi: 10.1016/j.bbr.2008.03.002
Wilcock G, Birks J, Whitehead A, Evans SJG (2002) The effect of selegiline in the treatment of people with Alzheimer’s disease: a meta-analysis of published trials. Int J Geriatr Psychiatry 17(2):175–183
pubmed: 11813282
doi: 10.1002/gps.545
Arib O, Rat P, Molimard R, Chait A, Faure P, de Beaurepaire R (2010) Electrophysiological characterization of harmane-induced activation of mesolimbic dopamine neurons. Eur J Pharmacol 629(1–3):47–52
pubmed: 20026027
doi: 10.1016/j.ejphar.2009.12.012
Bickford P, Adams C, Boyson S, Curella P, Gerhardt G, Heron C, Ivy G, Lin A et al (1997) Long-term treatment of male F344 rats with deprenyl: assessment of effects on longevity, behavior, and brain function. Neurobiol Aging 18(3):309–318
Carrillo M, Kanai S, Sato Y, Nokubo M, Ivy G, Kitani K (1993) The optimal dosage of (−) deprenyl for increasing superoxide dismutase activities in several brain regions decreases with age in male Fischer 344 rats. Life Sci 52(24):1925–1934
pubmed: 8505859
doi: 10.1016/0024-3205(93)90633-E
Carrillo M, Kitani K, Kanai S, Sato Y, Ivy G, Miyasaka K (1996) Long term treatment with (−) deprenyl reduces the optimal dose as well as the effective dose range for increasing antioxidant enzyme activities in old mouse brain. Life Sci 59(13):1047–1057
pubmed: 8809224
doi: 10.1016/0024-3205(96)00420-1
Muralikrishnan D, Samantaray S, Mohanakumar KP (2003) D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity. Synapse 50(1):7–13
pubmed: 12872288
doi: 10.1002/syn.10239
Zhang F, Lu J, Zhang J-g, Xie J-x (2015) Protective effects of a polysaccharide from Spirulina platensis on dopaminergic neurons in an MPTP-induced Parkinson’s disease model in C57BL/6J mice. Neural Regen Res 10(2):308–313
pubmed: 25883632
pmcid: 4392681
doi: 10.4103/1673-5374.152387
Arabi A, Karimi SA, Salehi I, Haddadi R, Komaki A (2023) Effects of sesamin on Aβ1-42-induced oxidative stress and LTP impairment in a rat model of Alzheimer’s disease. Metab Brain Dis 38(5):1503–1511
pubmed: 36847969
doi: 10.1007/s11011-023-01191-w
Basir HS, Mirazi N, Komaki A, Hosseini A (2024) Cacao consumption improves passive avoidance memory impairment in a rat model of Alzheimer’s disease: the role of hippocampal synaptic plasticity and oxidative stress. Front Pharmacol 15:1379264
pubmed: 38756381
pmcid: 11096498
doi: 10.3389/fphar.2024.1379264
Halder T, Patel B, Acharya N (2022) Design and optimization of myricetin encapsulated nanostructured lipid carriers: in-vivo assessment against cognitive impairment in amyloid beta (1–42) intoxicated rats. Life Sci 297:120479
pubmed: 35288172
doi: 10.1016/j.lfs.2022.120479
Puoyan-Majd S, Parnow A, Rashno M, Heidarimoghadam R, Komaki A (2024) The protective effects of high-intensity interval training combined with Q10 supplementation on learning and memory impairments in male rats with amyloid-β-induced Alzheimer’s disease. J Alzheimer’s Dis 99(s1):S67–S80
doi: 10.3233/JAD-230096
Gholipour P, Komaki A, Ramezani M, Parsa H (2022) Effects of the combination of high-intensity interval training and ecdysterone on learning and memory abilities, antioxidant enzyme activities, and neuronal population in an Amyloid-beta-induced rat model of Alzheimer’s disease. Physiol Behav 251:113817
pubmed: 35443198
doi: 10.1016/j.physbeh.2022.113817
Paxinos G, Watson C (2006) The rat brain in stereotaxic coordinates: hard cover. Elsevier
Harrison F, Hosseini A, McDonald M (2009) Endogenous anxiety and stress responses in water maze and Barnes maze spatial memory tasks. Behav Brain Res 198(1):247–251
pubmed: 18996418
doi: 10.1016/j.bbr.2008.10.015
Ghaderi S, Gholipour P, Komaki A, Shahidi S, Seif F, Bahrami-Tapehebur M, Salehi I, Zarei M et al (2024) Underlying mechanisms behind the neuroprotective effect of vanillic acid against diabetes-associated cognitive decline: an in vivo study in a rat model. Phytother Res 38(3):1262–77
Gholipour P, Ebrahimi Z, Mohammadkhani R, Ghahremani R, Salehi I, Sarihi A, Komaki A, Karimi SA (2024) Effects of (S)-3, 4-DCPG, an mGlu8 receptor agonist, on hippocampal long-term potentiation at perforant pathway-dentate gyrus synapses in prenatal valproic acid-induced rat model of autism. Sci Rep 14(1):13168
Gawel K, Gibula E, Marszalek-Grabska M, Filarowska J, Kotlinska JH (2019) Assessment of spatial learning and memory in the Barnes maze task in rodents—methodological consideration. Naunyn-Schmiedeberg’s Arch Pharmacol 392:1–18
doi: 10.1007/s00210-018-1589-y
Ahmadi N, Safari S, Mirazi N, Karimi SA, Komaki A (2021) Effects of vanillic acid on Aβ1-40-induced oxidative stress and learning and memory deficit in male rats. Brain Res Bull 170:264–273
pubmed: 33652070
doi: 10.1016/j.brainresbull.2021.02.024
Gholipour P, Komaki A, Parsa H, Ramezani M (2022) Therapeutic effects of high-intensity interval training exercise alone and its combination with ecdysterone against amyloid beta-induced rat model of Alzheimer’s disease: a behavioral, biochemical, and histological study. Neurochem Res 47:2090–108
pubmed: 35484426
doi: 10.1007/s11064-022-03603-2
Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361(6407):31–39
pubmed: 8421494
doi: 10.1038/361031a0
Lüscher C, Malenka RC (2012) NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harb Perspect Biol 4(6):a005710
pubmed: 22510460
pmcid: 3367554
doi: 10.1101/cshperspect.a005710
Hu Z, Yu P, Zhang Y, Yang Y, Zhu M, Qin S, Xu J-T, Duan D et al (2022) Inhibition of the ISR abrogates mGluR5-dependent long-term depression and spatial memory deficits in a rat model of Alzheimer’s disease. Transl Psychiatry 12(1):1–11
Salimi M, Tabasi F, Abdolsamadi M, Dehghan S, Dehdar K, Nazari M, Javan M, Mirnajafi-Zadeh J et al (2022) Disrupted connectivity in the olfactory bulb-entorhinal cortex-dorsal hippocampus circuit is associated with recognition memory deficit in Alzheimer’s disease model. Sci Rep 12(1):1–13
Yang Y, Ji W-g, Zhang Y-j, Zhou L-p, Chen H, Yang N, Zhu Z-r (2021) Riluzole ameliorates soluble Aβ1–42-induced impairments in spatial memory by modulating the glutamatergic/GABAergic balance in the dentate gyrus. Prog Neuropsychopharmacol Biol Psychiatry 108:110077
pubmed: 32818535
doi: 10.1016/j.pnpbp.2020.110077
Tofighi N, Asle-Rousta M, Rahnema M, Amini R (2021) Protective effect of alpha-linoleic acid on Aβ-induced oxidative stress, neuroinflammation, and memory impairment by alteration of α7 nAChR and NMDAR gene expression in the hippocampus of rats. Neurotoxicology 85:245–253
pubmed: 34111468
doi: 10.1016/j.neuro.2021.06.002
Okano M, Takahata K, Sugimoto J, Muraoka S (2019) Selegiline recovers synaptic plasticity in the medial prefrontal cortex and improves corresponding depression-like behavior in a mouse model of Parkinson’s disease. Front Behav Neurosci 13:176
pubmed: 31427934
pmcid: 6688712
doi: 10.3389/fnbeh.2019.00176
Srivastava I, Vazquez-Juarez E, Henning L, Gómez-Galán M, Lindskog M (2020) Blocking astrocytic GABA restores synaptic plasticity in prefrontal cortex of rat model of depression. Cells 9(7):1705
pubmed: 32708718
pmcid: 7408154
doi: 10.3390/cells9071705
Singh R, Mishra M, Singh S, Sharma D (2012) Effect of L-deprenyl treatment on electrical activity, Na+, K+ ATPase, and protein kinase C activities in hippocampal subfields (CA1 and CA3) of aged rat brain. Indian J Exp Biol 50(2):101–109
Briyal S, Ranjan AK, Gulati A (2023) Oxidative stress: a target to treat Alzheimer’s disease and stroke. Neurochem Int 165:105509
pubmed: 36907516
doi: 10.1016/j.neuint.2023.105509
Reed TT (2011) Lipid peroxidation and neurodegenerative disease. Free Radical Biol Med 51(7):1302–1319
doi: 10.1016/j.freeradbiomed.2011.06.027
Komaki H, Faraji N, Komaki A, Shahidi S, Etaee F, Raoufi S, Mirzaei F (2019) Investigation of protective effects of coenzyme Q10 on impaired synaptic plasticity in a male rat model of Alzheimer’s disease. Brain Res Bull 147:14–21
pubmed: 30721766
doi: 10.1016/j.brainresbull.2019.01.025
Chianeh YR, Prabhu K (2014) Protein thiols as an indicator of oxidative stress. Arch Med Rev J 23(3):443–456
Taysi S, Polat F, Gul M, Sari R, Bakan E (2002) Lipid peroxidation, some extracellular antioxidants, and antioxidant enzymes in serum of patients with rheumatoid arthritis. Rheumatol Int 21(5):200–204
pubmed: 11958437
doi: 10.1007/s00296-001-0163-x
Ayala A, Muñoz MF, Argüelles S (2014) Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid Med Cell Longev 2014:360438
pubmed: 24999379
pmcid: 4066722
doi: 10.1155/2014/360438
Benseny-Cases N, Klementieva O, Cotte M, Ferrer I, Cladera J (2014) Microspectroscopy (μFTIR) reveals co-localization of lipid oxidation and amyloid plaques in human Alzheimer disease brains. Anal Chem 86(24):12047–12054
pubmed: 25415602
doi: 10.1021/ac502667b
Nazifi M, Oryan S, Esfahani DE, Ashrafpoor M (2021) The functional effects of piperine and piperine plus donepezil on hippocampal synaptic plasticity impairment in rat model of Alzheimer’s disease. Life Sci 265:118802
pubmed: 33242524
doi: 10.1016/j.lfs.2020.118802
Tian Z, Wang X, Han T, Sun C (2023) Selegiline ameliorated dyslipidemia and hepatic steatosis in high-fat diet mice. Int Immunopharmacol 117:109901
pubmed: 36822098
doi: 10.1016/j.intimp.2023.109901
Wahdan SA, Tadros MG, Khalifa AE (2023) Retraction note to: antioxidant and antiapoptotic actions of selegiline protect against 3-NP-induced neurotoxicity in rats. Springer
Xie H, Hou S, Jiang J, Sekutowicz M, Kelly J, Bacskai BJ (2013) Rapid cell death is preceded by amyloid plaque-mediated oxidative stress. Proc Natl Acad Sci 110(19):7904–7909
pubmed: 23610434
pmcid: 3651444
doi: 10.1073/pnas.1217938110
Zhang J, Wu N, Wang S, Yao Z, Xiao F, Lu J, Chen B (2021) Neuronal loss and microgliosis are restricted to the core of Aβ deposits in mouse models of Alzheimer’s disease. Aging Cell 20(6):e13380
pubmed: 34080759
pmcid: 8208784
doi: 10.1111/acel.13380
Dunys J, Valverde A, Checler F (2018) Are N-and C-terminally truncated Aβ species key pathological triggers in Alzheimer’s disease? J Biol Chem 293(40):15419–15428
pubmed: 30143530
pmcid: 6177599
doi: 10.1074/jbc.R118.003999
Kiray M, Bagriyanik H, Pekcetin C, Ergur B, Uysal N, Ozyurt D, Buldan Z (2006) Deprenyl and the relationship between its effects on spatial memory, oxidant stress and hippocampal neurons in aged male rats. Physiol Res 55(2):205
pubmed: 15910165
doi: 10.33549/physiolres.930742